Molecular structure from independently sourced SMILES

Pirtobrutinib 2D structure

Role
Drug
Mechanism class
BTK inhibitor
InChIKey
FWZAWAUZXYCBKZ-NSHDSACASA-N
Structure checked
2026-10-08
Molecular formula
C22H21F4N5O3
Structure source
PubChem
PubChem CID
129269915
InChI Key
FWZAWAUZXYCBKZ-NSHDSACASA-N

Read the two structures

Locate the F labels and the connections around oxygen and nitrogen in pirtobrutinib, then compare those regions with ibrutinib. Describing attachment positions is more informative than counting element types alone. Structural observations remain separate from efficacy or binding-mode conclusions.

Acrylamide connectivityFluorine atoms
Differences measured by the selected structure queries
ObservationPirtobrutinibIbrutinib
Acrylamide connectivity01
Fluorine atoms40

Connect the structural observations with the fingerprint result

Ibrutinib has one C=C–C(=O)–N motif match and no fluorine match. Pirtobrutinib has no match for that motif and four fluorine atom matches. The drawings locate the selected connections and atoms independently. [Pirtobrutinib] · [Ibrutinib]

The complete fingerprints share 16 set bits across a union of 107, giving 0.150. A shared BTK class label and fingerprint proximity are different information: the class selects comparison subjects, while fingerprints compare encoded local connectivity.

Motif presence is a structural observation. This page performs no protein-binding or reactivity experiment, so a coloured motif is not evidence of covalent bond formation.

Calculated structural similarity: 0.150 · Morgan radius 2 / 2048 bits · Tanimoto

Calculation: 16 / (62 + 61 − 16) = 16 / 107 ≈ 0.150. Set-bit counts are not counts of unique atoms or functional groups.

Query definitions and reproducibility
  • Acrylamide connectivity: C=CC(=O)N
  • Fluorine atoms: [F]

RDKit 2025.03.4 · Matches with identical atom sets are counted once. Colours mark atoms and bonds matching selected queries, not a proven shared scaffold or synthesis route.

  1. Read elemental composition from the formulas.
  2. Trace ring and substituent connections in each drawing.
  3. Compare your observations with the fingerprint score calculated under identical settings.
  4. Check stereochemistry and the complete InChIKey in the source records.

The score is fingerprint overlap, not a percentage of efficacy or safety. RDKit

Structure-source check: 2026-10-08 / 2026-10-08 · Editorial update and calculation check: 2026-10-16

Download source structures, queries and bit counts for this comparison (JSON)

StructureMoa editorial · source review 2026-10-08

Molecular identity

Pirtobrutinib: independently retrieved PubChem CID 129269915, formula C22H21F4N5O3.

How to compare

Locate the F labels and the connections around oxygen and nitrogen in pirtobrutinib, then compare those regions with ibrutinib. Describing attachment positions is more informative than counting element types alone. Structural observations remain separate from efficacy or binding-mode conclusions.

Interpretation limits

The Morgan/Tanimoto score measures fingerprint overlap. It does not establish efficacy, safety, clinical superiority or full stereochemical identity.

SMILES

C[C@@H](C(F)(F)F)N1C(=C(C(=N1)C2=CC=C(C=C2)CNC(=O)C3=C(C=CC(=C3)F)OC)C(=O)N)N

Tags

BTKnon-covalent

Related compounds

Comparisons · briefs

External IDs · BioMoa

StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Editorial responsibility and corrections

Operated and edited by the independent StructureMoa project. Explanations use AI assistance; structural identity and similarity are checked against source records and calculation tests. Molecular data and clinical or regulatory evidence have separate review scopes.

Source structures
PubChem · CID / SMILES / InChIKey
Calculations and automated checks
RDKit · Morgan / SMARTS
Disclosed specialist review
No separate external specialist review is disclosed. Passing automated tests is not specialist review of clinical claims.

For a correction, include the page URL, molecule name or CID, the field in question and a supporting source. Corrections are checked against sources, and the affected editorial update date is changed when a correction is published. [email protected]